AGILENT TECHNOLOGIES, INC. vs AMETEK, Inc., two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where A and AME diverge most: on dividend yield, A reads 0.7% and AME reads 0.2%; on debt / equity, A reads 0.47 and AME reads 0.20. The rest of the comparable metrics sit closer together. What AME's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | A | AME |
|---|---|---|
| Price | $138.35 | $241.75 |
| Market cap | $39.2B | $55.6B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Mature | Mature |
| Implied growth (priced in) | — | +24.8% |
| P/E | 27.8 | 36.5 |
| P/B | 5.50 | 5.09 |
| P/S | 5.41 | 7.31 |
| EV/EBITDA | 25.1 | 23.9 |
| Revenue growth | +9.1% | +9.5% |
| Operating margin | 21.7% | 26.7% |
| Net margin | 19.6% | 20.1% |
| Return on equity | 19.9% | 14.0% |
| Return on assets | 10.8% | 9.4% |
| Return on invested capital | 12.3% | 12.2% |
| FCF yield | 2.8% | 3.1% |
| Dividend yield | 0.7% | 0.2% |
| Debt / equity | 0.47 | 0.20 |
| Current ratio | 2.10 | 1.14 |
| Altman Z (solvency) | 5.02 | 7.68 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.